Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · EW · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
43
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Edwards Lifesciences Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
EW insider buying and selling by quarter
EW insider selling · EW insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · EW ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
EW executive sell shares · EW board member insider trading · EW insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 29, 2026 | Dahl Andrew M. SVP, Corporate Controller | Sale | 567.527 | $49K | Form 4 |
| May 27, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | 23,145 | $2.00M⚡ | Form 4 |
| May 22, 2026 | Chopra Daveen CVP, TMTT & Surgical | Sale | 1,500 | $127K | Form 4 |
| May 18, 2026 | Lippis Daniel J. CVP, TAVR | Option | 620 | $45K | Form 4 |
| May 18, 2026 | Lippis Daniel J. CVP, TAVR | Sale | 620 | $50K | Form 4 |
| May 15, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | 8,000 | $655K | Form 4 |
| May 15, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | 9,968 | $818K | Form 4 |
| May 11, 2026 | Zovighian Bernard J CEO · Director | Option | 47,207 | — | Form 4 |
| May 11, 2026 | Zovighian Bernard J CEO · Director | Other | 26,198 | $2.09M⚡ | Form 4 |
| May 12, 2026 | Zovighian Bernard J CEO · Director | Gift | 26,640 | — | Form 4 |
| May 12, 2026 | Zovighian Bernard J CEO · Director | Gift | 26,640 | — | Form 4 |
| May 12, 2026 | Zovighian Bernard J CEO · Director | Sale | 845 | $66K | Form 4 |
| May 12, 2026 | Zovighian Bernard J CEO · Director | Sale | 35,506 | $2.77M⚡ | Form 4 |
| May 11, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option | 13,457 | — | Form 4 |
| May 11, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Other | 7,469 | $597K | Form 4 |
| May 11, 2026 | Chopra Daveen CVP, TMTT & Surgical | Option | 13,583 | — | Form 4 |
| May 11, 2026 | Chopra Daveen CVP, TMTT & Surgical | Other | 7,538 | $603K | Form 4 |
| May 11, 2026 | Ullem Scott B. CVP, Chief Financial Officer | Option | 19,830 | — | Form 4 |
| May 11, 2026 | Ullem Scott B. CVP, Chief Financial Officer | Other | 11,004 | $880K | Form 4 |
| May 7, 2026 | Markowitz Wayne CVP, JAPAC | Award | 5,200 | — | Form 4 |
| May 7, 2026 | Markowitz Wayne CVP, JAPAC | Other | 264 | $22K | Form 4 |
| May 8, 2026 | Markowitz Wayne CVP, JAPAC | Other | 226 | $19K | Form 4 |
| May 11, 2026 | Markowitz Wayne CVP, JAPAC | Sale | 593 | $47K | Form 4 |
| May 7, 2026 | Zovighian Bernard J CEO · Director | Award | 43,800 | — | Form 4 |
| May 7, 2026 | Zovighian Bernard J CEO · Director | Other | 4,153 | $346K | Form 4 |
Dahl Andrew M.
SVP, Corporate Controller
Date
May 29
Shares
567.527
Price
$86.08
Value
$49K
BOBO DONALD E JR
CVP,Strategy/Corp Development
Date
May 27
Shares
23,145
Price
$86.42
Value
$2.00M ⚡
Chopra Daveen
CVP, TMTT & Surgical
Date
May 22
Shares
1,500
Price
$84.60
Value
$127K
BOBO DONALD E JR
CVP,Strategy/Corp Development
Date
May 15
Shares
8,000
Price
$81.82
Value
$655K
BOBO DONALD E JR
CVP,Strategy/Corp Development
Date
May 15
Shares
9,968
Price
$82.07
Value
$818K
Zovighian Bernard J
CEO · Director
Date
May 11
Shares
26,198
Price
$79.96
Value
$2.09M ⚡
Zovighian Bernard J
CEO · Director
Date
May 12
Shares
35,506
Price
$77.92
Value
$2.77M ⚡
BOBO DONALD E JR
CVP,Strategy/Corp Development
Date
May 11
Shares
13,457
Price
—
Value
—
BOBO DONALD E JR
CVP,Strategy/Corp Development
Date
May 11
Shares
7,469
Price
$79.96
Value
$597K
Chopra Daveen
CVP, TMTT & Surgical
Date
May 11
Shares
7,538
Price
$79.96
Value
$603K
Ullem Scott B.
CVP, Chief Financial Officer
Date
May 11
Shares
19,830
Price
—
Value
—
Ullem Scott B.
CVP, Chief Financial Officer
Date
May 11
Shares
11,004
Price
$79.96
Value
$880K
Zovighian Bernard J
CEO · Director
Date
May 7
Shares
4,153
Price
$83.20
Value
$346K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About EW insider trading
EW insider trades
Edwards Lifesciences Corporation (EW) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Zovighian Bernard J (CEO · Director), Lippis Daniel J. (CVP, TAVR), Ullem Scott B. (CVP, Chief Financial Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. EW insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Edwards Lifesciences Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
EW insider trading · 5 questionsThe insiders of Edwards Lifesciences Corporation (EW) include executives and directors such as Zovighian Bernard J (CEO · Director), Lippis Daniel J. (CVP, TAVR), Ullem Scott B. (CVP, Chief Financial Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026